Because these medications can significantly suppress appetite, theyve become increasingly popular for people seeking medical weight management, not just those with diabetes
It essentially presses the pause button on microbial growth, which is indispensable when you're working with a multi-use vial that will be punctured multiple times
A summary of randomized controlled trials (RCTs) on these cognitive parameters is presented below
Risk factors that may influence the decision to pause treatment include: Being in the dose-escalation phase of GLP-1 therapy Experiencing active gastrointestinal symptoms (nausea, vomiting, bloating) Having known gastroparesis or other conditions affecting gastric emptying Taking concurrent medications that further delay gastric emptying (e.g., opioids) Undergoing procedures with higher aspiration risk (e.g., emergency surgery, airway surgery) If your anaesthetist or surgical team advises temporary cessation based on your individual risk assessment, the timing will depend on the specific medication: Daily injections (such as liraglutide): Typically paused 24 hours before surgery Weekly injections (such as semaglutide, dulaglutide): Often paused with the last dose given at least 7 days before surgery Oral semaglutide (Rybelsus): Usually paused 24 hours before surgery However, these timings may vary according to local NHS Trust protocols and individual clinical assessment
FASgen noted that the compounds were effective orally and were easily absorbed from the intestine
Dont rush to the highest dosea sustainable and effective dose is better than the maximum dose if it means you can stick with the treatment
